SecurityUS90290PAS39 / U.S. Renal Care, Inc., 1st Lien Term Loan C - 10.60718% 2028-06-20
InstitutionPcm Fund, Inc.
Latest Disclosed Value $ 1,934,853
Pcm Fund, Inc. ownership in US90290PAS39 / U.S. Renal Care, Inc., 1st Lien Term Loan C

2025-08-29 - Pcm Fund, Inc. has filed a NPORT-P form disclosing ownership of U.S. Renal Care, Inc., 1st Lien Term Loan C (US:US90290PAS39) valued at $1,934,853 USD as of 2025-06-30. Pcm Fund, Inc. had filed a previous NPORT-P on 2025-05-30 disclosing shares of U.S. Renal Care, Inc., 1st Lien Term Loan C valued at of $1,911,259 USD. This represents a change in value of 1.20 percent during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-29 2025-06-30 NP U S RENAL CARE INC 2023 SUPERPRIORITY TERM LOAN LON US90290PAS39 1,935 1.20 2.6418
2025-05-30 2025-03-31 NP U S RENAL CARE INC 2023 SUPERPRIORITY TERM LOAN LON US90290PAS39 1,911 -0.68 2.5924
2025-03-03 2024-12-31 NP U S RENAL CARE INC 2023 SUPERPRIORITY TERM LOAN LON US90290PAS39 1,924 2.34 2.5782
2024-11-27 2024-09-30 NP U S RENAL CARE INC 2023 SUPERPRIORITY TERM LOAN LON US90290PAS39 1,881 3.98 2.4204
2024-08-29 2024-06-30 NP U S RENAL CARE INC 2023 SUPERPRIORITY TERM LOAN LON US90290PAS39 1,808 0.22 2.3937
2024-05-29 2024-03-31 NP U S RENAL CARE INC 2023 SUPERPRIORITY TERM LOAN LON US90290PAS39 1,804 14.32 2.3011
2024-02-27 2023-12-31 NP U S RENAL CARE INC 2023 SUPERPRIORITY TERM LOAN LON US90290PAS39 1,578 13.53 2.0205
2023-11-28 2023-09-30 NP U S RENAL CARE INC 2023 SUPERPRIORITY TERM LOAN LON US90290PAS39 1,390 1.8284
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.